Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Yang M, Zu K, Mucci LA, Rider JR, Fiorentino M, Clinton SK, et al. Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade. Cancer Causes Control. 2016;27(8):1043-7.

Sarwar M, Semenas J, Miftakhova R, Simoulis A, Robinson B, Wingren AG, et al. Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells. Oncotarget. 2016;7(39):63065-63081.

Zhao Z, Zhu X, Cui K, Mancuso J, Federley R, Fischer K, et al. In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors. Cancer Res. 2016;76(8):2094-2104.

Staunton L, Tonry C, Lis R, Finn S, Leary JO, Loda M, et al. Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LC⿿MS⿿A technical report. EuPA Open Proteom. 2016;10:19-23.

Sboner A, Elemento O. A primer on precision medicine informatics. Brief Bioinform. 2016;17(1):145-53.

Goss C, Avecilla ST, Garbaini J, Degtyaryova D, Lo D, Chang DY, et al. Can the interval between antibody identifications be increased for alloimmunized patients? Transfusion. 2016;56(2):334-8.

Magro CM, Momtahen S, Verma S, Abraham RM, Friedman C, Nuovo GJ, et al. Cutaneous myeloid dendritic cell dyscrasia: A cutaneous clonal monocytosis associated with chronic myeloproliferative disorders and peripheral blood monocytosis. Ann Diagn Pathol. 2016;25:85-91.

Hsu Y-, Cushing MM. Autologous Stem Cell Mobilization and Collection. Hematol Oncol Clin North Am. 2016;30(3):573-89.

Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J, et al. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell. 2016;164(5):896-910.

Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian X-, et al. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016;40(6):847-56.